Robert Mashal, Director at Nuvation Bio Inc. (NUVB), bought 199,981 shares at $2.20 ($440K) on 2024-10-08, disclosed to the SEC on 2024-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 19 | $42 | 0.0% |
| 2 | $2.20 | 99,981 | $220K | 50.0% |
| 3 | $2.20 | 99,981 | $220K | 50.0% |
| Total | $2.20 avg | 199,981 | $440K | 100% |
| Filing → |